● Recruiting

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

Condition: Diabetic Foot Infection · Sponsor: MicuRx

PhasePhase 3

Planned participants865

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linezolid (IV and PO) administered for a total of 14 to 28 days in adult subjects with moderate or severe DFI.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical coordinator · 510-782-2022 · info@micurx.com

Always discuss trial participation with your own doctor first.

Locations (14)

New Hope Research Development	Corona, California, United States	Recruiting
ILD Research Center	Vista, California, United States	Recruiting
MHAT Sveti Nikolay Chudotvorets EOOD	Lom, Bulgaria	Recruiting
Multiprofile Hospital for Active Treatment - KANEV	Rousse, Bulgaria	Recruiting
Medical Institute Ministry of Interior Central Clinical Base	Sofia, Bulgaria	Recruiting
University Multidisciplinary Hospital for Active Treatment and Emergency Medicine 'N. I. Priogov´	Sofia, Bulgaria	Recruiting
South-Estonian Hospital Ltd.	Võru, Estonia	Recruiting
LTD High Technology Hospital Med Center	Batumi, Georgia	Recruiting
JSC Vian - West Georgia Medical Center	Kutaisi, Georgia	Recruiting
GMV Care& Research - Maria Cecilia Hospital	Cotignola, Italy	Recruiting
Daugavpils Regional Hospital	Daugavpils, Latvia	Recruiting
Instytut Medycyny Wsi im. W. Chodzki	Lublin, Poland	Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05369052